Details
Building on our long‑standing commitment to the sickle cell disease (SCD) community, Pfizer is advancing the Sickle Cell Advocacy & Leadership Empowerment (SCALE) grant program, a competitive initiative designed to support research and community‑based programs that accelerate policy change.
The full application can be seen here. Applications open March 17th 2026 and are due by May 13th 2026.